» Articles » PMID: 37432158

Vitamin D and Probability of Developmental Disorders Among Perinatally HIV-Affected and Unaffected Ugandan Children

Overview
Journal Nutrients
Date 2023 Jul 11
PMID 37432158
Authors
Affiliations
Soon will be listed here.
Abstract

We tested the hypothesis that vitamin D deficiency (VDD) is associated with higher developmental disorder probability in 604 children with perinatal HIV infection (CPHIV, = 199), HIV exposed and uninfected (CHEU, = 196), and HIV unexposed uninfected (CHUU, = 201). Children at 6-18 years old and their adult caregivers were assessed at enrollment, 6, and 12-month follow-ups. Serum 25-hydroxyvitamin-D (25OHD) levels in children quantified per the NHANES protocol were used to define VD categories as VDD (25OHD < 20 ng/mL), VD insufficient (VDI, 20 ≤ 25OHD ≤ 25 ng/mL), and VD sufficient (VDS = reference group if 25OHD > 25 ng/mL). Perinatal HIV status per DNA polymerase chain reaction/HIV rapid diagnostic tests included: CPHIV, CHEU, and CHUU. Developmental stage was defined as pre-adolescent (age < 11) vs. adolescent (age ≥ 11) years. Caregiver responses to standardized questions from Behavioral Assessment System for Children, Third Edition (BASC-3), were used to calculate probability scores for four disorders, namely: autism (ASD), attention deficit & hyperactivity (ADHD), emotional behavioral disorder (EBD), functional impairment (FI), and resiliency at 0, 6 and 12 months. Multivariable longitudinal models estimated VD-associated standardized mean difference (SMD) and corresponding 95% confidence intervals (95% CI) in respective probability scores in Statistical Analysis Software (v.9.4). Baseline VDD vs. VDS predicted higher probability scores of moderate clinical importance for ASD, ADHD, EBD, and higher FI among pre-adolescents (SMD = 0.32 to 0.40, 95% CI: 0.00 to 0.74). VDD was not associated with resiliency or any developmental disorders among adolescents. VDD predicted higher developmental disorder and FI scores over 12 months in a developmental stage-dependent manner. This relationship requires further understanding to appropriately target future interventions.

References
1.
Wang Z, Ding R, Wang J . The Association between Vitamin D Status and Autism Spectrum Disorder (ASD): A Systematic Review and Meta-Analysis. Nutrients. 2021; 13(1). PMC: 7824115. DOI: 10.3390/nu13010086. View

2.
Mirza A, Wells S, Gayton T, Smotherman C, Rathore A, Kraemer D . Vitamin D Deficiency in HIV-Infected Children. South Med J. 2016; 109(11):683-687. DOI: 10.14423/SMJ.0000000000000556. View

3.
Orkin C, Wohl D, Williams A, Deckx H . Vitamin D deficiency in HIV: a shadow on long-term management?. AIDS Rev. 2014; 16(2):59-74. View

4.
Pinzone M, Di Rosa M, Malaguarnera M, Madeddu G, Foca E, Ceccarelli G . Vitamin D deficiency in HIV infection: an underestimated and undertreated epidemic. Eur Rev Med Pharmacol Sci. 2013; 17(9):1218-32. View

5.
Alfieri D, Lehmann M, Oliveira S, Flauzino T, Delongui F, de Araujo M . Vitamin D deficiency is associated with acute ischemic stroke, C-reactive protein, and short-term outcome. Metab Brain Dis. 2016; 32(2):493-502. DOI: 10.1007/s11011-016-9939-2. View